Raymond James Financial »

Coeptis Therapeutics Hldgs I shares owned by Raymond James Financial

Quarter-by-quarter ownership of Coeptis Therapeutics Hldgs I (COEP) shares owned by Raymond James Financial from 13F filings

Historical chart of Raymond James Financial investment in Coeptis Therapeutics Hldgs I

Tip: Access up to 7 years of quarterly data

All positions including Coeptis Therapeutics Hldgs I held by Raymond James Financial consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Coeptis Therapeutics Hldgs I by Raymond James Financial

Quarter filed Position value Share count Share price at filing
2025-06-30 $8 1 8.00

More positions owned by Raymond James Financial

Vanguard Index Fds S&p 500 Etf Shs (VOO)
Microsoft Corporation (MSFT)
Ishares Tr Core Us Aggbd Et (AGG)
Apple (AAPL)
NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Amazon (AMZN)
JPMorgan Chase & Co. (JPM)
Ishares Tr Core Msci Eafe (IEFA)
Alphabet Cap Stk Cl A (GOOGL)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Meta Platforms Cl A (META)
Ishares Tr Core S&p500 Etf (IVV)
Wal-Mart Stores (WMT)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Raymond James Financial

Top funds holding Coeptis Therapeutics Hldgs I

Vanguard Group
Geode Capital Management
State Street Corporation
Renaissance Technologies
Yorkville Advisors Global
Steward Partners Investment Advisory
Pnc Financial Services
Barclays

View all funds holding Coeptis Therapeutics Hldgs I